Kidney Transplant Market to Reach US$ 15.49 Billion by 2033 as Demand for Advanced Organ Transplant Procedures Accelerates

DataM Intelligence has released a new research report titled "Kidney Transplant Market Size 2026". The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the global Kidney Transplant Market.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/kidney-transplant-market?ram

The Global Kidney Transplant Market reached US$ 8.86 Billion in 2025 and is expected to reach US$ 15.49 Billion by 2033, growing at a CAGR of 7.65% during the forecast period 2026-2033.

The market is experiencing significant growth due to the rising prevalence of chronic kidney disease (CKD), end-stage renal disease (ESRD), diabetes, and hypertension, which continue to increase the global demand for kidney transplantation procedures. Expanding organ donation awareness programs, improvements in transplant success rates, and advancements in immunosuppressive therapies are further supporting market expansion across developed and emerging healthcare systems.

Key Industry Developments

United States:
✅ April 2026: TransMedics Group unveiled its new Controlled Hypothermic Organ Preservation System (CHOPS) during the ISHLT 2026 Annual Meeting. The technology was introduced to enhance organ preservation logistics and support advanced transplant clinical programs, including kidney and multi-organ transplantation workflows.

✅ January 2026: Bridge to Life received U.S. FDA De Novo clearance for its VitaSmart Hypothermic Oxygenated Perfusion (HOPE) System. The launch marked a major advancement in transplant preservation technology, enabling broader adoption of oxygenated perfusion methods designed to improve donor organ viability and transplant outcomes.

✅ October 2025: Paragonix Technologies advanced commercialization of its KidneyVault Portable Renal Perfusion System following FDA 510(k) clearance. The portable preservation platform was designed to improve donor kidney transportation, monitoring, and temperature-controlled perfusion during transplant procedures.

Japan:
✅ April 2026: Rege Nephro Co., Ltd. announced U.S. FDA Orphan Drug Designation for Tamibarotene targeting autosomal dominant polycystic kidney disease (ADPKD). The milestone strengthened Japan's regenerative kidney therapy pipeline and supported international clinical expansion for innovative renal treatment development.

✅ March 2026: Ministry of Health, Labour and Welfare granted approval for the world's first commercial iPS cell-derived regenerative therapies in Japan. The approvals reinforced Japan's leadership in regenerative medicine and accelerated innovation applicable to future kidney regenerative and transplant technologies.

✅ October 2025: Japan External Trade Organization launched the Japan Entry Acceleration Program (JEAP) focused on regenerative medicine and cell therapy startups. The initiative encouraged international collaboration and commercialization of advanced regenerative technologies relevant to kidney disease treatment and transplantation research.

Strategic Acquisitions & Partnerships
✅ Terumo Corporation - Acquisition
(August, 2025)
Terumo Corporation announced the acquisition of OrganOx, a developer of organ preservation and normothermic machine perfusion technologies used in liver and kidney transplantation. The deal was aimed at expanding Terumo's presence in the organ transplantation sector and strengthening its long-term growth strategy in transplant-related medical technologies.

✅ Biogen - Strategic Partnership
(April, 2025)
TJ Biopharma joined Biogen-sponsored international Phase 3 clinical trials evaluating felzartamab for immune-mediated kidney diseases, including antibody-mediated rejection in kidney transplant recipients. The partnership expanded Biogen's transplant immunology development footprint in China and supported broader commercialization and clinical development efforts in renal transplantation-related indications.

Key Players:
Key players are Transonic, Sanofi S.A., Organ Recovery Systems, Inc., Pfizer Inc., TransMedics Inc., Novartis AG, Preservation Solutions Inc., B. Braun Melsungen AG, Medtronic plc, Fresenius Medical Care AG & Co.

Key Highlights: Top 5 Key Players in Kidney Transplant Market 2026
-TransMedics Inc.: Expanded its Organ Care System (OCS) platform for organ preservation and transplantation, with continued advancement of the OCS Kidney program and launch preparations for international kidney transplant applications. The company also enhanced its National OCS Program (NOP) and introduced the OCS Connect mobile platform for real-time organ logistics visibility and transplant coordination.

-Sanofi S.A.: Strengthened its transplant immunology portfolio through continued support of immunosuppressive therapies used in kidney transplantation and expanded research collaborations focused on improving graft survival and reducing rejection risks in transplant recipients.

-Pfizer Inc.: Advanced its immunosuppressive treatment portfolio supporting kidney transplant patients, focusing on optimized long-term rejection prevention strategies and patient-centric therapeutic management solutions for post-transplant care.

-Transonic: Enhanced intraoperative transplant monitoring through its transit-time ultrasound flow measurement technology, enabling surgeons to quantitatively assess renal graft blood flow, detect vascular complications before closure, and improve transplant graft viability during kidney transplant procedures.

-Organ Recovery Systems, Inc.: Continued expanding organ preservation technologies for kidney transplantation through advanced hypothermic machine perfusion systems designed to improve donor kidney preservation quality, extend viable transport time, and support higher transplant success rates globally.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/kidney-transplant-market?ram

Main Drivers and Trends Shaping the Future of the Kidney Transplant Market
-Organ Shortage and Rising CKD Cases: The increasing prevalence of chronic kidney disease (CKD), diabetes, and hypertension is significantly driving demand for kidney transplantation as a long-term treatment option for end-stage renal disease (ESRD).

-Technological Advancements: Innovations in organ preservation systems, robotic-assisted transplant surgeries, and improved Human Leukocyte Antigen (HLA) matching technologies are enhancing transplant success rates and patient outcomes.

-Immunosuppressive Therapy Development: Continuous advancements in immunosuppressive drugs are reducing organ rejection risks, improving graft survival, and supporting long-term transplant viability.

-Government and Healthcare Support: Growing investments in transplant infrastructure, awareness campaigns for organ donation, and favorable reimbursement policies are accelerating market growth globally.

-Market Challenges: Limited donor availability, high transplant and post-operative care costs, ethical concerns regarding organ allocation, and risks of transplant rejection and infection continue to restrain broader market expansion.

Regional Insights:
-North America: 40.3% (Largest market share, driven by advanced transplant infrastructure, strong organ donation frameworks, and high prevalence of chronic kidney disease and ESRD).

-Europe: 24.8% (Strong market presence supported by rising organ donation rates, advanced transplant technologies, and favorable healthcare policies across countries such as Germany, Spain, and the UK).

-Asia Pacific: 17.5% (Fastest-growing region, fueled by improving healthcare infrastructure, increasing CKD cases, government support, and rising medical tourism in China, India, and Japan).

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=kidney-transplant-market?ram

Market Segmentation Analysis:
-By Product Type: Preservation and Surgical Solutions Lead Clinical Efficiency
Preservation and storage devices play a vital role in maintaining organ viability during transport, supporting successful transplant outcomes. Surgical equipment remains essential for precision-based transplant procedures and minimally invasive techniques. Dialysis equipment continues to support patients awaiting transplantation and post-operative recovery management. Other consumables, including immunosuppressive support products and monitoring accessories, contribute to overall transplant workflow efficiency and patient care.

-By Transplant Type: Living Donor Transplants Remain Highly Preferred
Living donor transplants are widely adopted due to shorter waiting times and improved graft survival rates. Paired kidney transplants are expanding through donor-matching programs that improve compatibility between unrelated donor-recipient pairs. Deceased donor transplants remain critical for addressing organ shortages globally.

-By Preservation Method: Advanced Perfusion Technologies Gain Attention
Hypothermic machine perfusion (HMP) is increasingly used to improve organ preservation quality and reduce ischemic injury. Static cold storage (SCS) remains widely practiced because of its simplicity and cost-effectiveness. Normothermic machine perfusion (NMP) is gaining traction for enabling real-time organ assessment before transplantation.

-By Age Group: Adult Population Dominates Transplant Demand
Adults represent the largest patient group due to rising chronic kidney disease and diabetes prevalence. Pediatric kidney transplantation focuses on congenital and hereditary kidney disorders, while geriatric patients increasingly require transplants due to age-related renal complications.

-By End User: Hospitals and Transplant Centers Lead Procedures
Hospitals remain the primary end users because of advanced surgical infrastructure and multidisciplinary transplant teams. Specialty clinics support pre- and post-transplant monitoring services. Dedicated transplant centers are expanding globally with specialized expertise in organ transplantation and long-term patient management.

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTW

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicated reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.